A prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesions in small vessels: The PERSEUS Small Vessel trial

EuroIntervention

Volumn 6, Issue 8, 2011, Pages 920-927

  Cannon, Louis A ^a   Kereiakes, Dean J ^b   Mann, Tift ^c   Popma, Jeffrey J ^d   Mooney, Michael R ^e   Mishkel, Gregory J ^f   Lee, Tommy C ^g   Wilson, B Hadley ^h   Stuckey, Thomas D ⁱ   Orlow, Steven ^j   McGarry, Thomas ^k   Ring, Michael E ^l   Kellett, Mirle A ^m   Underwood, Paul ⁿ   Dawkins, Keith D ⁿ  

^a Northern Michigan Regional Hospital   (United States)

^b The Carl & Edyth Lindner Center for Research & Education   (United States)

^c WAKEMED HEALTH AND HOSPITALS   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^f ST JOHN'S HOSPITAL   (United States)

^g Bakersfield Memorial Hospital   (United States)

^h CAROLINAS MEDICAL CENTER   (United States)

ⁱ LeBauer Cardiovascular Research Foundation   (United States)

^j Lutheran Hospital Fort Wayne   (United States)

^k Oklahoma Foundation for Cardiovascular Research   (United States)

^l SACRED HEART MEDICAL CENTER   (United States)

^m MAINE MEDICAL CENTER   (United States)

ⁿ BOSTON SCIENTIFIC CORPORATION   (United States)

more..

Author keywords

Coronary restenosis; Drug eluting stents; Paclitaxel; Platinum chromium; Small vessel; Thin strut

Indexed keywords

PACLITAXEL;

ADULT; ARTERY DIAMETER; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DEVICE SAFETY; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; STENT THROMBOSIS; SURGICAL MORTALITY; THERAPY EFFECT; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CHROMIUM COMPOUNDS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; EQUIPMENT FAILURE ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; PLATINUM COMPOUNDS; PROSPECTIVE STUDIES;

EID: 79954501970     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV6I8A161     Document Type: Article

References (14)

1. Akiyama T, Moussa I, Reimers B, Ferraro M, Kobayashi Y, Blengino S, Di Francesco L, Finci L, Di Mario C, Colombo A. Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels. J Am Coll Cardiol. 1998;32:1610-8. (Pubitemid 28545198)
2. Kereiakes DJ. Coronary small-vessel stenting in the era of drug elution. Rev Cardiovasc Med. 2004;5 Suppl 2:S34-45.
3. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O'Shaughnessy CD, DeMaio S, Hall P, Popma JJ, Koglin J, Russell ME. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA. 2005;294:1215-23. (Pubitemid 41352109)
4. Ellis SG, Stone GW, Cox DA, Hermiller J, O'Shaughnessy C, Mann T, Turco M, Caputo R, Bergin PJ, Bowman TS, Baim DS. Long-Term Safety and Efficacy With Paclitaxel-Eluting Stents: 5-Year Final Results of the TAXUS IV Clinical Trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent). J Am Coll Cardiol Intv. 2009;2:1248-59.
5. Turco MA, Ormiston JA, Popma JJ, Hall JJ, Mann T, Cannon LA, Webster MWI, Mishkel GJ, O'Shaughnessy CD, McGarry TF, Mandinov L, Dawkins KD, Baim DS. Reduced Risk of Restenosis in Small Vessels and Reduced Risk of Myocardial Infarction in Long Lesions With the New Thin-Strut TAXUS Liberté Stent: 1-Year Results From the TAXUS ATLAS Program. J Am Coll Cardiol Intv. 2008;1:699-709.
6. O'Brien BJ, Stinson JS, Larsen SR, Eppihimer MJ, Carroll WM. A platinum-chromium steel for cardiovascular stents. Biomaterials. 2010;31:3755-61.
7. Allocco DJ, Cannon LA, Britt A, Heil JE, Nersesov A, Wehrenberg S, Dawkins KD, Kereiakes DJ. A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: Design and statistical methods of the PERSEUS clinical program. Trials. 2010;11:1.
8. Wilson GJ, Huibregtse BA, Stejskal EA, Crary J, Starzyk RM, Dawkins KD, Barry JJ. Vascular Response to a Third Generation Everolimus-Eluting Stent. EuroIntervention. 2010;6:512-519.
9. Soucy NV, Feygin JM, Tunstall R, Casey MA, Pennington DE, Huibregtse BA, Barry JJ. Strut tissue coverage and endothelial cell coverage: a comparison between bare metal stent platforms and platinum chromium stents with and without everolimus-eluting coating. EuroIntervention. 2010;6:630-637.
10. King SB, 3rd, Smith SC, Jr., Hirshfeld JW, Jr., Jacobs AK, Morrison DA, Williams DO, Feldman TE, Kern MJ, O'Neill WW, Schaff HV, Whitlow PL, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention. Circulation. 2008;117:261-95.
11. Nakazawa G, Finn AV, Vorpahl M, Ladich E, Kutys R, Balazs I, Kolodgie FD, Virmani R. Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis. J Am Coll Cardiol. 2009;54:1924-31.
12. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344-51. (Pubitemid 46685903)
13. Turco MA, Ormiston JA, Popma JJ, Mandinov L, O'Shaughnessy CD, Mann T, McGarry TF, Wu CJ, Chan C, Webster MW, Hall JJ, Mishkel GJ, Cannon LA, Baim DS, Koglin J. Polymer-based, paclitaxel-eluting TAXUS Liberte stent in de novo lesions: The Pivotal TAXUS ATLAS Trial. J Am Coll Cardiol. 2007;49:1676-83. (Pubitemid 46589927)
14. Kereiakes DJ, Cannon LA, Feldman RL, Magorien R, Whitbourn R, Dauber IM, Rabinowitz AC, Ball MW, Bertolet B, Kabour A, Foster MC, Wang JC, Underwood P, Dawkins KD. Clinical and Angiographic Outcomes After Treatment of de novo Coronary Stenoses with a Novel Platinum Chromium Thin-Strut Stent: Primary Results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) Trial. J Am Coll Cardiol. 2010;56:264-71.